TY - JOUR
T1 - A case of bullous pemphigoid treated with plasmapheresis and pulse cyclophosphamide
AU - Kang, H.
AU - Sang Hyun Cho, Hyun Cho
AU - Tae Yoon Kim, Yoon Kim
AU - Baik Kee Cho, Kee Cho
AU - Houh, W.
PY - 1993
Y1 - 1993
N2 - A 54-year-old woman with severe bullous pemphigoid (BP) associated with insulin dependent diabetes mellitus (DM), who showed unresponsiveness to conventional therapy with corticosteroids in combination of either cyclosporine or dapsone, was successfully treated with plasmapheresis followed each time by 3 successive days of pulse therapy of cyclophosphamide (500mg, intravenously). After six times of plasmapheresis, anti-basement membrane zone (BMZ) antibody titer decreased from 1:1280 to 1:40 and no new lesions developed at all. In severe refractory BP patients with uncontrolled DM, plasmapheresis is one of the valuable treatment modalities for a short period and the need for corticosteroids thus avoiding corticosteroid induced side effects. Herein we report a case of BP with uncontrolled DM who showed an excellent response to a low dose of corticosteroid and 150mg oral azathioprine following plasmapheresis and cyclophosphamide pulse therapy.
AB - A 54-year-old woman with severe bullous pemphigoid (BP) associated with insulin dependent diabetes mellitus (DM), who showed unresponsiveness to conventional therapy with corticosteroids in combination of either cyclosporine or dapsone, was successfully treated with plasmapheresis followed each time by 3 successive days of pulse therapy of cyclophosphamide (500mg, intravenously). After six times of plasmapheresis, anti-basement membrane zone (BMZ) antibody titer decreased from 1:1280 to 1:40 and no new lesions developed at all. In severe refractory BP patients with uncontrolled DM, plasmapheresis is one of the valuable treatment modalities for a short period and the need for corticosteroids thus avoiding corticosteroid induced side effects. Herein we report a case of BP with uncontrolled DM who showed an excellent response to a low dose of corticosteroid and 150mg oral azathioprine following plasmapheresis and cyclophosphamide pulse therapy.
UR - https://www.scopus.com/pages/publications/0027141926
U2 - 10.5021/ad.1993.5.2.146
DO - 10.5021/ad.1993.5.2.146
M3 - Article
AN - SCOPUS:0027141926
SN - 1013-9087
VL - 5
SP - 146
EP - 150
JO - Annals of Dermatology
JF - Annals of Dermatology
IS - 2
ER -